Data as of Mar 14
| +0.01 / +0.32%|
The 3 analysts offering 12-month price forecasts for InspireMD Inc have a median target of 6.00, with a high estimate of 7.00 and a low estimate of 5.00. The median estimate represents a +92.31% increase from the last price of 3.12.
The current consensus among 3 polled investment analysts is to Buy stock in InspireMD Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.